Sign inJoin waitlistJoin the waitlist

Michael Sy

Associate Professor, Neurology · University of California

Credentials: · · · ·

History

University of California
Present

University of California
2011–2014
University of California, Irvine School of Medicine
2007–2011

Research

Inflammation induced by infection potentiates tau pathological features in transgenic mice
American Journal Of Pathology · 2011 · First of 7 authors · 181 citations
Molecular defects underlying the Kell null phenotype
Case report · Journal of Biological Chemistry · 2001 · 60 citations
N-acetylglucosamine drives myelination by triggering oligodendrocyte precursor cell differentiation
Journal of Biological Chemistry · 2020 · First of 13 authors · 39 citations

Michael Demetriou
8 papers
Anastasia Chumakova
3 papers
Piyanuch Kongtim
2 papers
Stefan Ciurea
2 papers
AC
Amit Chaudhari
1 paper · 1 as a resident
AO
Annette Okai
1 paper
Christopher Bartley
1 paper
David Swope
1 paper
Div Dubey
1 paper
ES
Eshita Shah
1 paper · 1 as a fellow
Haik Mkhikian
1 paper · 1 as a resident
IP
Ingrid Perez-Alvarez
1 paper · 1 as a fellow

Grants

Oral N-Acetylglucosamine as Anti-Neuroinflammatory Add-on Therapy for Multiple Sclerosis (NANA-MS)
National Institute of Allergy and Infectious Diseases · R34
PI · $263.9K · University of California-Irvine
2025–2027

Clinical trials

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
Site PI · Recruiting
SetPoint Medical Corporation
2026–2030
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2025–2031